U. Hadding

The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus

F.-J. Schmitz, Ad C. Fluit, Marc Lückefahr et al. · Journal of Antimicrobial Chemotherapy · 1998 · 159 citations · Full text

Staphylococcus Aureus, In-vitro Activities, Pharmacotherapy +17

Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B

Willy A. Flegel, Frank Müller, Walter Däubener et al. · Infection and Immunity · 1991 · 156 citations · Full text

Inflammation, Cytokine, Microbial Toxin +13

Rosmarinic acid: A new inhibitor of complement C3-convertase with anti-inflammatory activity

Werner Englberger, U. Hadding, E. Etschenberg et al. · International Journal of Immunopharmacology · 1988 · 130 citations

Inflammation, Complement C3-convertase, Anti-inflammatory +7

Characterization of <i>grlA</i> , <i>grlB</i> , <i>gyrA</i> , and <i>gyrB</i> Mutations in 116 Unrelated Isolates of <i>Staphylococcus aureus</i> and Effects of Mutations on Ciprofloxacin MIC

Franz‐Josef Schmitz, Mark E. Jones, B. Hofmann et al. · Antimicrobial Agents and Chemotherapy · 1998 · 128 citations · Full text

Unrelated Isolates, Microbial Pathogens, Klebsiella Pneumoniae +18

Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related

C. von Eichel-Streiber, U. Harperath, Diane Bosse et al. · Microbial Pathogenesis · 1987 · 112 citations

Microbial Toxin, Toxinology, Clostridium Difficile +6